specific immunoglobulin

Specific immunoglobulin (Nanyue Bio) is a preclinical-stage plasma-derived biologic being developed by Nanyue Biopharmaceutical for the prevention and treatment of specific infectious diseases. This asset represents a program to produce hyperimmune globulins from the human plasma of donors with high titers of antibodies against a particular, though currently undisclosed, pathogen. The mechanism of action is passive immunization, which provides immediate protection by delivering concentrated antibodies that neutralize the target pathogen or its toxins, thereby preventing infection or mitigating disease severity. This approach is typically used for post-exposure prophylaxis or as an adjunctive treatment for severe infections where immediate immunity is required.

Other names

Specific ImmunoglobulinNanyue Bio specific immunoglobulin